Bausch Health Companies (TSE:BHC) Sets New 1-Year Low – What’s Next?

Bausch Health Companies Inc. (TSE:BHC)’s stock price hit a new 52-week low on Wednesday . The stock traded as low as C$6.71 and last traded at C$6.72, with a volume of 496491 shares traded. The stock had previously closed at C$6.93.

Bausch Health Companies Trading Down 1.6%

The company has a market capitalization of C$2.48 billion, a price-to-earnings ratio of -2.05, a P/E/G ratio of 0.21 and a beta of 0.94. The company has a debt-to-equity ratio of -1,009.96, a quick ratio of 0.58 and a current ratio of 1.32. The business’s 50-day simple moving average is C$7.49 and its 200-day simple moving average is C$8.19.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 EPS for the quarter. The company had revenue of C$3.51 billion during the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive return on equity of 120.43%. On average, research analysts expect that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.